Rocket Buys Rival Million: A Smart Move for Investors
Rocket Lab is expanding by purchasing a competing space systems group for up to $60 million. This article breaks down...
Target date funds adjust asset allocations over time toward a chosen retirement year, simplifying diversification and rebalancing for many savers.
19,808 articlesRocket Lab is expanding by purchasing a competing space systems group for up to $60 million. This article breaks down...
Teva is shifting from a debt-laden generic player to a branded-focused pharma with a stronger balance sheet. This piv...
Two major South Florida MLS networks merged in a record-breaking deal, creating a unified platform for listings and m...
Brookfield plans value per share offers a long‑term lens on value. This guide explains the metric, how it links to th...
A dramatic legal verdict against a tech titan could reshape how investors view AI, crypto, and venture risk. This art...
Synopsys posted a strong Q1 FY2026 showing AI-enabled design work driving revenue and backlog, fueling bets the stock...
Bezos pushes back on Mamdani’s tactic of painting opponents as villains, arguing real solutions require skill. The NY...
Regulators and banks frame XRP's path as traders debate a remote target. This report lays out what would be required ...
When Berkshire Hathaway named Greg Abel to lead investments, the portfolio made a surprising pivot. This article brea...
SpaceX’s IPO filing reveals a company pivoting from rockets to AI infrastructure, with heavy spending and a long road...
Chevron sits at the heart of today’s energy debate: steady production, looming supply gaps, and the question every in...
A major investment bank just signaled a powerful vote of confidence in Lilly's GLP-1 strategy. This article breaks do...